EXCESS ANNUAL MORTALITY FROM NOSOCOMIAL INFECTIONS CAUSED BY MULTIDRUG RESISTANT BACTERIA IN THAILAND
Author(s)
Phodha T1, Riewpaiboon A2, Malathum K3, Coyte PC4
1Faculty of Pharmacy, Mahidol University, Saimai, 10, Thailand, 2Faculty of Pharmacy, Mahidol University, Bangkok, Thailand, 3Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 4Institute of Health Policy Management and Evaluation, School of Public Health, University of Toronto, Toronto, ON, Canada
OBJECTIVES: This study aims to estimate the excess annual mortality from nosocomial infection caused by multi-drug resistant (MDR) bacteria in Thailand. METHODS: A retrospective case cohort study was conducted at Ramathibodi Hospital, Bangkok, one of the largest tertiary care hospitals in Thailand, between January 1st, 2008 and December 31st, 2012. A multivariate Cox proportional hazard regression model was used to estimate the excess mortality incidence rate of antimicrobial resistance (AMR) relative to those patients without resistance (non-AMR) after controlling for an array of potential confounders including the Charlson co-morbidity score. RESULTS: The overwhelming majority of patients with nosocomial infection (73.80%) were MDR cases over the study period, 2008 – 2012. Patients in the AMR and non-AMR groups had similar comorbidities, severity of baseline diseases, and sites of infection. Compared to patients in the non-AMR group, the mortality incidence rate for patients in the AMR group (susceptibility group = 1) who had acquired A, E, P. aeruginosa, and Swere 92%, 25%, 60%, and 84% higher, respectively, but 16% lower for patient who had acquired Kpneumoniae CONCLUSIONS: In the complete absence of MDR bacteria, this study estimated that annually, in Thailand, there would be 111,295 fewer AMR cases, 48,258 fewer deaths and 123,000 fewer hospitalization days.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PIN15
Topic
Clinical Outcomes
Topic Subcategory
Relating Intermediate to Long-term Outcomes
Disease
Infectious Disease (non-vaccine)